ZA956106B - A polynucleotide herpes virus vaccine - Google Patents

A polynucleotide herpes virus vaccine

Info

Publication number
ZA956106B
ZA956106B ZA956106A ZA956106A ZA956106B ZA 956106 B ZA956106 B ZA 956106B ZA 956106 A ZA956106 A ZA 956106A ZA 956106 A ZA956106 A ZA 956106A ZA 956106 B ZA956106 B ZA 956106B
Authority
ZA
South Africa
Prior art keywords
polynucleotide
herpes virus
virus vaccine
vaccine
herpes
Prior art date
Application number
ZA956106A
Inventor
Marcy E Armstrong
Robert D Keys
John A Lewis
Margaret A Liu
William L Mcclements
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA956106B publication Critical patent/ZA956106B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA956106A 1994-07-22 1995-07-21 A polynucleotide herpes virus vaccine ZA956106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27945994A 1994-07-22 1994-07-22

Publications (1)

Publication Number Publication Date
ZA956106B true ZA956106B (en) 1996-04-10

Family

ID=23069059

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956106A ZA956106B (en) 1994-07-22 1995-07-21 A polynucleotide herpes virus vaccine

Country Status (10)

Country Link
EP (1) EP0772680A1 (en)
JP (1) JPH10503649A (en)
AU (1) AU708460B2 (en)
CA (1) CA2195099A1 (en)
CO (1) CO4410257A1 (en)
HR (1) HRP950412A2 (en)
IL (1) IL114576A0 (en)
WO (1) WO1996003510A1 (en)
YU (1) YU49995A (en)
ZA (1) ZA956106B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849719A (en) * 1993-08-26 1998-12-15 The Regents Of The University Of California Method for treating allergic lung disease
AU738835B2 (en) * 1994-07-22 2001-09-27 Merck & Co., Inc. A polynucleotide herpes virus vaccine
US7094767B2 (en) 1994-07-22 2006-08-22 Merck & Co., Inc. Polynucleotide herpes virus vaccine
CA2267645A1 (en) * 1996-10-01 1998-04-09 Merck & Co., Inc. A polynucleotide herpes virus vaccine
JP2001503257A (en) * 1996-10-18 2001-03-13 バレンティス・インコーポレーテッド IL-12 gene expression and delivery systems and uses
AU4908197A (en) * 1996-10-18 1998-05-15 Valentis, Inc. Gene expression and delivery systems and uses
GB9720633D0 (en) * 1997-09-29 1997-11-26 Univ Bristol BHV-2 vector
JP2002502884A (en) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー Vaccine comprising interleukin-12 and herpes simplex virus antigen
US6867000B2 (en) * 2000-12-07 2005-03-15 Wyeth Holdings Corporation Method of enhancing immune responses to herpes
US9012349B1 (en) 2013-11-01 2015-04-21 Ut-Battelle Llc Method of synthesizing bulk transition metal carbide, nitride and phosphide catalysts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751664T2 (en) * 1986-08-01 1996-06-05 Commw Scient Ind Res Org RECOMBINANT VACCINE
ATE240401T1 (en) * 1989-03-21 2003-05-15 Vical Inc EXPRESSION OF EXOGENEOUS POLYNUCLEOTIDE SEQUENCES IN VERTEBRATES
ATE123065T1 (en) * 1989-07-07 1995-06-15 Takeda Chemical Industries Ltd PROTEINS AND THEIR PRODUCTION.

Also Published As

Publication number Publication date
JPH10503649A (en) 1998-04-07
WO1996003510A1 (en) 1996-02-08
AU708460B2 (en) 1999-08-05
IL114576A0 (en) 1995-11-27
HRP950412A2 (en) 1997-10-31
YU49995A (en) 1998-05-15
CA2195099A1 (en) 1996-02-08
CO4410257A1 (en) 1997-01-09
AU3101295A (en) 1996-02-22
EP0772680A1 (en) 1997-05-14

Similar Documents

Publication Publication Date Title
IL108915A0 (en) Polynucleotide vaccine against influenza virus
AP9701060A0 (en) Hepatitis B vaccine
HU9500417D0 (en) Hepatitis a vaccine
GB9410922D0 (en) Vaccines
ZA956106B (en) A polynucleotide herpes virus vaccine
GB9420146D0 (en) Papillomavirus vaccine
HU9203976D0 (en) Vaccine based on modified herpes virus
GB2322130B (en) A vaccine against Simian Herpes B virus
ZA957482B (en) Vaccine
GB9419969D0 (en) Vaccine
GB9413517D0 (en) Viral vaccines
GB9406708D0 (en) Vaccines
GB9109763D0 (en) Herpes virus vaccine
GB9305710D0 (en) Viral vaccines
GB9324964D0 (en) Viral vaccines
GB9406480D0 (en) Vaccine
GB9412470D0 (en) Vaccine
GB9423928D0 (en) Vaccine
GB9620856D0 (en) Virus vaccine
GB9421007D0 (en) Virus
GB9420956D0 (en) Virus
GB9405990D0 (en) Vaccines
GB9418057D0 (en) Vaccines
ZA952370B (en) Vaccines
ZA956796B (en) Vaccines